Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Weak Retail Hits U.S. Markets

Published 01/09/2014, 04:06 PM
Updated 07/09/2023, 06:31 AM

Stocks finish unchanged to slightly lower as pressure on retail stocks weighed on the broader markets, eroding all of the gains tied to better-than-expected initial jobless claims. Disappointing earnings from Bed Bath and Beyond (BBBY) and Family Dollar (FDO) pulled the entire sector deep into negative territory. And even though the Nasdaq touched a new high, the tech-heavy index closed with a small loss as a result of selling pressure on Apple (AAPL) and Google (GOOG).

Thursday's disappointing close is also blamed on a lack of trader conviction going into Friday's pivotal jobs report. Although the Federal Reserve has already announced plans to begin scaling back quantitative easing this month, the possibility for more aggressive tapering may hinge on the status of the job market.

Jobs Speculation
After Wednesday's strong ADP report and Thursday's continued decline in new unemployment claims, some analysts are forecasting the jobless rate to fall below 7% for the first time in 5 years.

Initial jobless claims fell 15,000 for the week ended January 4, a much greater decline than expected, driving down the 4-week average to 349,000 from 357,250.

European markets lost ground in sympathy with the U.S. stock market, as well as on remarks from European Central Bank President Mario Draghi who thinks weak economic conditions warrant additional stimulus measures.

Here's where the markets stand at the close:

US MARKETS

  • Dow Jones Industrial Index was down 17.89 (-.1%) to 16,444.76
  • S&P 500 was up 0.6 (+0.04%) to 1,838.13 
  • Nasdaq Composite Index was down 9 (-0.2%) to 4,156.19
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
GLOBAL SENTIMENT
  • FTSE 100 was down 0.45%
  • Nikkei 225 was down 1.50% 
  • Hang Seng Index was down 0.91% 
  • Shanghai China Composite Index was down 0.82%
UPSIDE MOVERS
  • ICPT Trial to study obeticholic adic for the treatment of nonalcoholic steatohepatitis has been stopped earlier than planned after already meeting the primary endpoint.
  • CRDC Received 510(k) clearance of its MicroCutter XCHANGE 30 device and blue staple cartridge for medium thickness tissue from the U.S. FDA for certain uses. 
  • MONT Preliminary revenue for Q4 was $35 to $35.5 million, exceeding its previously announced guidance of $32 million to $34 million.
DOWNSIDE MOVERS
  • FDML Downgraded by Goldman Sachs to Sell from Neutral
  • AEZS, AEZ.TO Offered 11.0 million units at $1.20 each for net proceeds of about $12.2 million.. 
  • PIR Reported December same-store-sales fell 5.7%
After Hours Stock News From Midnight Trader.

Copyright © 2014 MT Newswires, a Division of MidnightTrader, Inc.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.